U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

BioAge Labs

Market Cap: US$168.9m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Rallybio

Market Cap: US$24.5m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Editas Medicine

Market Cap: US$226.6m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Day One Biopharmaceuticals

Market Cap: US$759.0m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

REGENXBIO

Market Cap: US$490.5m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

ALT5 Sigma

Market Cap: US$483.5m

Provides blockchain-powered technologies worldwide.

Pliant Therapeutics

Market Cap: US$100.1m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Celcuity

Market Cap: US$2.3b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Actinium Pharmaceuticals

Market Cap: US$52.7m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

TNF Pharmaceuticals

Market Cap: US$6.4m

A clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.

Recursion Pharmaceuticals

Market Cap: US$2.0b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

Apimeds Pharmaceuticals US

Market Cap: US$23.4m

Operates as a clinical stage biopharmaceutical company in the United States.

Genprex

Market Cap: US$5.2m

A clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.

CRISPR Therapeutics

Market Cap: US$4.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Nuvalent

Market Cap: US$5.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Sangamo Therapeutics

Market Cap: US$160.0m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.

Forte Biosciences

Market Cap: US$195.4m

Operates as a clinical-stage biopharmaceutical company in the United States.

Acumen Pharmaceuticals

Market Cap: US$83.6m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Alpha Cognition

Market Cap: US$134.9m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

60 Degrees Pharmaceuticals

Market Cap: US$6.1m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

Personalis

Market Cap: US$451.4m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Crinetics Pharmaceuticals

Market Cap: US$3.2b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Rigel Pharmaceuticals

Market Cap: US$719.8m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

iBio

Market Cap: US$15.9m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.

Alector

Market Cap: US$285.4m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Organogenesis Holdings

Market Cap: US$638.1m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

KalVista Pharmaceuticals

Market Cap: US$796.4m

A biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

Myriad Genetics

Market Cap: US$615.0m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Angion Biomedica

Market Cap: US$30.1m

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States.

Olema Pharmaceuticals

Market Cap: US$435.8m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Voyager Therapeutics

Market Cap: US$215.2m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Tenaya Therapeutics

Market Cap: US$202.1m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

BioNTech

Market Cap: US$24.9b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

TC Biopharm (Holdings)

Market Cap: US$532.1k

A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.

Axsome Therapeutics

Market Cap: US$6.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.